Historical links regarding Ivermectin pre, Corrupt FDA awarded, "Emergency Use Authorization" (legal protection CON) to the pre-planned Toxic Biotech Jabs

It's one thing to fight for what medication clinicians claim are effective, it's another believing in the false "virus" cause & receiving toxic jabs prevents people "catching and spreading" it.

This article will be linked to my main Ivermectin article.

• "Alternative" Cures for the novel "2019 Flu-like" detox - Ivermectin (here)

The Globalsist Stakeholders’ Club enjoyed the benefits of alternative drugs being perceived as a cure against their Imaginary “virus.” The Highwire with Dr. Pierre Kory has even written a book on Ivermectin being the wonder cure against the fictitious “SARS-CoV-2 virus.” It’s not that they didn’t know that they would have to use the media, the FDA, the CDC, the WHO and others to play the game of never fully accepting any of these supposed “anti-viral” options before their toxic mass murdering jabs were pushed through i.e. given a libilty protecting “Emegency Use Authorization.” Once enough jabs had been pushed on the masses and these toxic products were closer to being put on the childhood schedule, they could allow their controlled Mainstream Media to be more open to the use of Ivermectin. Some believe that even the use of Ivermectin is also part of the con, i.e, don’t receive the toxic jab or take Ivermectin. What I can say is, the Health Freedom Movement may be winning some small battles, good or bad, but as long as they remain ignorant as to the trickery and pseudoscientific “isolation” and everything else that has been added on to the “virus” fairytale, mankind will lose the WAR.

Besides Google using their search engine to herd the public into a pro-vaxsin ideology, they also use their YouTube to good effect in this regard. YouTube not only didn’t allow anyone to speak negatively against Pharmakeia’s jabs by using “being in line with the WHO’s virus/jab BS,” but they also blocked many “anti-vax” exposing videos and activists’ accounts. The people had to fight hard for the medications they wanted to use against the “novel flu-like symptoms”, while Pharmakeia used their Globalist partners-in-crime to support the health-compromising “CVD” Jabs. Even though RFK Jr. could stop these toxic jabs that have now been put on the childhood schedule, it’s more likely that again it will only happen through the people rising up to put an end to these toxic Pharmakeia biotech weapons.

• Petition - WE DEMAND URGENT ACCESS TO IVERMECTIN FOR ALL (here)

• ClinicalTrials.gov Ivermectin | Studies with results (here)

TrialSite New Historical Links on Ivermectin

One must understand that two major assumptions are made with most “Scientific” papers with regard to “efficacy” against the invisible “SARS-CoV-2 virus”. The first is a belief in virology as a whole, i.e, that the antibodies measured relate to a “virus” and that our bodies work in accordance with this “virus fairytale,” i.e, it’s an “infection” vs. it being an OUT-fection. The second is whether any “data” collected from the RT-PCR test has any meaning.

• Medical Index - Exposing "Virology", Genetic Sequencing & The "Health Freedom Movement" (here)

• Medical Index - The Creation of Plandemic (here)

TrialSiteNews.com has done a spectacular job of chronicling the research and implementation of Ivermectin around the world. Below is a handy list of all of the articles that they have published regarding the use of Ivermectin as a preventative and therapeutic agent for people who test positive for coronavirus or suffer symptoms of COVID-19.

Click on the links below to read the articles about Ivermectin.

February 11, 2021
Making it not easy to obtain Ivermectin and making it controversial regarding it being able to stop the “invisible virus” from “entering the cell” was important, but falsely marketing the “authorized” jabs as being able to help people protect Grandma from “contracting” the “invisible virus” was what the Jab All Killers needed their controlled Governments and Mainstream Media to do more than ever.
Kathrada spoke out about the controversial drug after it became known that the recovery rate increased dramatically from 88% to 92% over the past week.
Ivermectin changed course of Covid-19 pandemic in SA, claims doctor (here)

JANUARY 19, 2021
The first toxic “CVD” jab was given the legally protective Emergency Use Authorization on December 11, 2020. By the time the National Institutes of Health (NIH) was allowed to upgrade its recommendation for the use of Ivermectin by making it an option for use in treating “COVID-19,” within the United States, they had already conned the masses into believing the toxic vaxsin “stopped transmission” and was “Actually” effective as apposed to “Relatively” effective.
‘Miraculous’ ivermectin approved for use in the US for the treatment of COVID-19 (here)

JANUARY 11, 2021 - 18:36 TAMAR KAHN
The use of ivermectin for preventing or treating COVID-19 is “risky and unethical” as there is insufficient evidence to show it is safe and effective, the government’s top coronavirus advisers have warned.
“Until more robust evidence is available, the routine use of ivermectin for either the prevention or treatment of Covid-19 is not justified,” health minister Zweli Mkhize’s advisory committee on Covid-19 said in guidance provided to him last week...
Using ivermectin for COVID-19 is risky and unethical, say government advisers (here)

DECEMBER 14, 2020
Clinical Trials and Research Roundup | Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?
​Introducing the Physicians for Civil Defense: Prominent Doctors Know #Ivermectin can Help Treat COVID-19: Will Anyone Listen? A group calling itself Physicians for Civil Defense, as it turns out, is a group of physicians, TrialSite Knows..

DECEMBER 13, 2020
Fact Checking the Fact Checkers: The Case of Ivermectin for Publicly-Subsidized Research
On December 11, TrialSite reported on a US Senate hearing at which, among other things, there was testimony urgently calling for more research and an EUA for ivermectin as both a prophylactic against and an early treatment for COVID-19. As we recently covered, there...

DECEMBER 12, 2020
Beyond The Roundup | Senate Hearing On Ivermectin Brings Unexpected Drama
​The Senate Homeland Security and Governmental Affairs Committee heard from medical professionals who advocate for alternative coronavirus treatments and mitigation measures than those at the National Institutes of Health, Centers for...

DECEMBER 11, 2020
​Introducing the Physicians for Civil Defense: Prominent Doctors Know Ivermectin Can Help Treat COVID-19: Will Anyone Listen?
A group calling itself Physicians for Civil Defense, as it turns out, is a group of physicians TrialSite Knows very well. In fact, they include Dr. Jacques Rajter of Fort Lauderdale, Florida, co-principal investigator and author of the ICON study, which evidences the efficacy...

DECEMBER 11, 2020
US Senate Hearing Explores Ivermectin as “Miracle Drug” for COVID-19, While Mainstream Media Outlets Ignore
On December 8, the US Senate Homeland Security and Governmental Affairs Committee held a hearing formally titled, “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II.” The focus of the hearing was testimony from frontline physicians as to...

DECEMBER 9, 2020
Senate Homeland Security Committee Holds Hearing on the COVID-19 Pandemic: Learn About the Promise of Ivermectin
The Senate Homeland Security and Governmental Affairs Committee heard from medical professionals who advocate for alternative coronavirus treatments and mitigation measures than those at the National Institutes of Health, Centers for Disease Control and Prevention,...

DECEMBER 9, 2020
ICDDR Dhaka Bangladesh, Completes Successful Ivermectin Clinical Trial
The International Center for Diarrheal Disease Research (ICDDR) in Dhaka, Bangladesh, reported that a clinical trial investigating ivermectin has proven significantly effective in treating COVID-19 patients in this country. With findings recently disclosed by the..

DECEMBER 7, 2020
Clinical Trials and Research News Weekly Roundup | Ivermectin Repurposing for COVID-19: The Israeli Perspective
‘Generic Drug Repurposing for COVID-19” The Israeli Perspective’:Tel Aviv University’s Spark program recently hosted a webinar titled “Generic Drug Repurposing for COVID-19: The Israeli Perspective.” In collaboration with the MedInsight...

DECEMBER 5, 2020
Prominent Physician/Researchers to Present Case for Ivermectin to U.S. Senate Committee on Homeland Security & Governmental Affairs
The U.S. Senate Committee on Homeland Security & Governmental Affairs will hold a full committee hearing on December 8, 2020, at 10:00 AM at the Senate Dirksen Building and via video conference. Titled “Early Outpatient Treatment: An Essential Part of a COVID-19...

NOVEMBER 25, 2020
Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43
Dr. Pierre Kory Talks Covid-19, Ivermectin, and the FLCCC:Dr. Pierre Kory, Associate Professor of Medicine at St. Luke’s Aurora Medical Center and who TrialSite News would classify as a Pulmonologist and ICU specialist dedicated completely to the COVID-19 patient. He...

NOVEMBER 16, 2020
Clinical Trials and Research News Weekly Roundup | I-MASK+: Ivermectin Key For Early Treatment
Real World Evidence? #I-MASK+ Protocol: #Ivermectin Key for Prophylaxis and Early Treatment of # COVID-19: Real world evidence (RWE) means medical evidence obtained from real world data (RWD), that is, observational data, secured from...

NOVEMBER 15, 2020
Why Isn’t Ivermectin Being Widely Researched and Utilized?
On November 13, a scientific review manuscript was posted to OSF, a medical pre-print server by Pierre Kory, MD, of the Front Line COVID-19 Critical Care Alliance (FLCCC). On November 3, TrialSite reported on the inclusion of the drug in the Alliance’s I-MASK+...

NOVEMBER 14, 2020
Benha University Breakthrough: Randomized Controlled Trial Shows Ivermectin Effective for Treating COVID-19 & as Prophylaxis
A principal investigator with Egypt’s Benha University and team recently concluded a clinical trial titled ‘Efficacy and Safety of Ivermectin for Treatment and Prophylaxis of COVID-19 Pandemic.’ The results, now available on the preprint server, are promising....

NOVEMBER 7, 2020
AIIMS Bhubaneswar Study Evidencing Prophylactic Evidence of Ivermectin Targeting COVID-19: Indian Press Active
The recent AIIMS Bhubaneswar study evidencing ivermectin as a potential prophylactic against COVID-19 has generated more activity in the Indian press than typically observed with other studies centering on the U.S. Food and Drug Administration (FDA) approved...

NOVEMBER 5, 2020
Indian and Iraqi Studies Suggest Ivermectin Prevents and Treats COVID-19
As TrialSite recently covered, evidence is mounting that Ivermectin is effective as both a prophylactic to prevent COVID-19 infections and a potent treatment. Now, two new studies in pre-print add to the Ivermectin picture. Of course, ideally, these studies shall be...

NOVEMBER 3, 2020
Real World Evidence? I-MASK+ Protocol: Ivermectin Key for Prophylaxis and Early Treatment of COVID-19
Real-world evidence (RWE) means medical evidence obtained from real-world data (RWD), that is, observational data, secured from outside the context of clinical trials and rather produced during routine clinical practice. The 21st Century Cures Act, enacted as law in...

OCTOBER 28, 2020
​Dr. Paul Marik: Ivermectin Works and Should be Accepted for Large Observational Studies
Dr. Paul Marik is a critical care physician who teaches medicine at Eastern Virginia Medical School. Known for a vitamin C sepsis cocktail currently under clinical investigation, he recently posted an in-depth YouTube lecture with a dire warning for Americans and the...

OCTOBER 28, 2020
Argentinian Preclinical Animal Research Reveals Potential Ivermectin-based Nasal Spray Targeting SARS-CoV-2
Multiple research centers, including universities and Laboratorio Elea Phoenix (Elea Laboratories) from Argentina, recently concluded preclinical animal research investigating the safety and pharmacokinetic attributes of an experimental, novel nasal spray-based...

OCTOBER 23, 2020
India’s ICMR Excludes Ivermectin from National Guidelines for COVID-19: Not Sufficient Evidence via RCTs
Although some Indian states, such as Uttar Pradesh, allow for the use of Ivermectin off-label as a treatment option as well as a prophylaxis for COVID-19, sources recently shared with Indian media that the Indian Council of Medical Research (ICMR)’s National Task Force...

OCTOBER 19, 2020
Clinical Trials and Research News Weekly Roundup | India State’s Health Authority Approves Ivermectin
Goa Game Changer: Indian State’s Health Authority Approves & Distributes Ivermectin & Doxycycline to Treat COVID-19 as Prophylaxis: Goa’s Chief Minister Pramod Sawant, alongside State Health Minister Vishwajit Rane, launched the...

OCTOBER 14, 2020
​MATH+ Protocol Includes Ivermectin Option for Prophylaxis and Early Treatment of COVID-19; Phase of Disease Key to Care
“MATH+” is the COVID-19 protocol by Dr. Paul Marik and the Front Line Covid-19 Critical Care Alliance (FLCCC), as previously reported by TrialSite. And while NIH is still recommending ivermectin be used only in clinical trials, the September 28 update to MATH+...

OCTOBER 13, 2020
​ICON Study Evidencing Efficacy of Ivermectin Against COVID-19 Published in Peer-Reviewed Journal Chest
TrialSite News has followed the work of Dr. Jean-Jacques Rajter, Juliana Cepelowicz, and team from Broward County Health and their leadership of the ICON study. Initially published via the preprint server, TrialSite proudly announces that the peer-review journal...

OCTOBER 11, 2020
Dhaka Medical College Shares Results of Randomized Controlled Trial: Ivermectin & Doxycycline Benefits Patients with Mild to Moderate COVID-19
Dhaka Medical College and Hospital, a public medical college and hospital based in Dhaka, the capital of Bangladesh, houses one of the most prestigious medical schools and the country’s largest tertiary care hospital. Known as the most advanced of health institutions...

OCTOBER 10, 2020
Goa Game Changer: Indian State’s Health Authority Approves & Distributes Ivermectin & Doxycycline to Treat COVID-19 as Prophylaxis
Goa’s Chief Minister Pramod Sawant, alongside State Health Minister Vishwajit Rane launched the ‘Home Isolation Kit’ to combat COVID-19. Apparently, the Indian state was influenced by Australia’s Dr. Thomas Borody and his combination treatment involving ivermectin and...

OCTOBER 8, 2020
TrialSite News Research Contributes to Indian Physicians Call for Ivermectin-based Research Targeting COVID-19
According to a brief mention in the Times of India, a recent white paper discussing the potential of Ivermectin as a treatment for SARS-CoV-2 has been embraced by the World Health Organization (WHO). Published in the Indian Journal of Tuberculosis Elsevier, the recent...

OCTOBER 7, 2020
Brookdale University Hospital Physicians Peer Review Position: Study Inhaled Form Ivermectin for COVID-19 Now
A group of physicians from Brookdale University Hospital Medical Center in Brooklyn, New York, had their manuscript published in the peer-reviewed journal Cureus recently. The team reminds all that with the advent of SARS-CoV-2, the virus behind COVID-91, the quest for...

OCTOBER 1, 2020
Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works.
The COVID-19 patient was in critical condition and declining quickly. “Speak to your mom now,” the pulmonologist recalled telling her son, “because after this you may not be able to.” The son pleaded: Was there something else the doctor...\

SEPTEMBER 30, 2020
President of One of Largest Dominican Republic Private Health Systems: Ivermectin has Helped Treat 6,000 Patient
The president of one of Dominican Republic’s largest private health systems, Rescue Group, interviewed by TrialSite, recently was profiled in Dominican Today with Doris Pantaleón. Dr. José Natalio Redondo, president of the Rescue Group, was recently profiled as a...

SEPTEMBER 29, 2020
​France-based MedinCell Initiates Ivermectin Clinical Trial Targeting COVID-19 with Prophylactic Strategy
MedinCell treated the first patient in a clinical trial aimed at validating the safety of continuous administration of Ivermectin in an oral form. Several long-acting injectable formulations based on MedinCell's BEPO® technology are simultaneously being tested in...

SEPTEMBER 28, 2020
Mymensingh Medical College Retrospective Study: Ivermectin Superior to Standard of Care for COVID-19 Patients
Recently, a Japanese and Bangladeshi-led research team completed a retrospective study involving 325 consecutive patients infected with SARS-CoV-2 at the COVID-19 treatment unit at Mymensingh Medical College hospital (MMCH), Mymensingh, Bangladesh from April to June...

SEPTEMBER 28, 2020
Clinical Trials and Research News Weekly Roundup | Ivermectin Treatment in Three Brazilian Towns
An Old Drug Tackles New Tricks: Ivermectin Treatment in Three Brazilian Towns: TrialSite News continues to develop a global network of individuals, from all walks of life, participating and sharing their experiences from around the...

SEPTEMBER 26, 2020
Argentina Study Supports Ivermectin for COVID-19
Argentina’s largest newspaper, Clarin, reported on September 23 about positive results in an ivermectin study, including reduced viral loads, in a study conducted in that nation. Clarin posits that this, “is the first scientific evidence available in the world, which...

SEPTEMBER 25, 2020
New Proteomics Analysis May Show How Ivermectin Fights COVID-19
A new article in the Journal of Cellular Physiology from September 22 looks at a real-world problem: while we do have some evidence that ivermectin is useful for COVID-19, the mechanism by which the drug works has been less clear. Noting that ivermectin inhibits...

SEPTEMBER 23, 2020
Peer-Reviewed Results of Bangladesh Medical College Prospective Study: Ivermectin & Doxycycline Combination Effectively Treats Mild to Moderate COVID-19
The Journal of Bangladesh College of Physicians and Surgeons accepted the first case series study authored by Dr. Tarek Alam working with the Bangladesh Medical College. TrialSite showcased these results after an interview with Dr. Alam. Titled “A Case Series of 100...

SEPTEMBER 21, 2020
Clinical Trials and Research News Weekly Roundup | FDA Greenlight for Ivermectin Clinical Trial
Southern California Research Institute Receives FDA Greenlight for Ivermectin Clinical Trial: California’s ProgenaBiome recently received the green light from the U.S. Food and Drug Administration (FDA) for two Phase 2 clinical trials...

SEPTEMBER 17, 2020
Prominent Japanese Academic Medical Center Launching Ivermectin Clinical Trial Targeting COVID-19
Distinguished Japanese professor Omura Satoshi won the Nobel Prize for discovering a compound that led to the development of ivermectin. Now, his university, Kitasato University Hospital, will conduct a major clinical trial to investigate whether the anti-parasite drug...

SEPTEMBER 16, 2020
​An Old Drug Tackles New Tricks: Ivermectin Treatment in Three Brazilian Towns
TrialSite News continues to develop a global network of individuals from all walks of life, participating and sharing their experiences from around the world. They share a common bond: a dedication to health, community well-being, and research, from randomized...

SEPTEMBER 15, 2020
Bodoland University Researcher Suggests In Silica Study Points to Ivermectin Promise Targeting SARS-COV-2
A researcher from Bodoland University reports on a study investigating the binding property of ivermectin on four critical drug targets, including 1) spike protein, 2) RNA-dependent RNA polymerase, 3) 3-chymotrypsin-, and 4) papain-like proteases of SARS-CoV-2, the...

SEPTEMBER 14, 2020
Clinical Trials and Research News Weekly Roundup | Ivermectin Moves Towards Mainstream
Ivermectin Moves Towards Mainstream: Recently, the National Institutes of Health (NIH) got around to formally addressing ivermectin in their COVID-19 Treatment Guidelines. Although their only recommendation is for use in clinical trials,...

SEPTEMBER 11, 2020
Fact Check in India: ICMR Doesn’t Include Ivermectin in Treatment Guidelines: Contrary to Internet Claims
The Indian government hasn’t included ivermectin in its treatment guidelines, although apparently there are claims on social media of the contrary. In fact, ICMR hasn’t recommended the use of the anti-parasite drug for the treatment of COVID-19. As TrialSite...

SEPTEMBER 10, 2020
Southern California Research Institute Receives FDA Greenlight for Ivermectin Clinical Trial
California’s ProgenaBiome recently received the green light from the U.S. Food and Drug Administration (FDA) for two Phase 2 clinical trials involving investigational therapies targeting COVID-19: one of them based on hydroxychloroquine and the other ivermectin. With...

SEPTEMBER 7, 2020
Anti-Inflammatory Action of Ivermectin Surveyed in Literature Review
In clinical use since 1981 as an oral and topical medicine for a range of parasitic infection, ivermectin is on WHO’s List of Essential Medications. Anecdotally, the standard dose of 9mg used once has been correlated with some instances of “rapid clinical resolution...

SEPTEMBER 7, 2020
Clinical Trials and Research News Weekly Roundup | Zagazig University Ivermectin VS COVID-19
Zagazig University Randomized Controlled Ivermectin Study Results Confirm PI Hypothesis: Drug Effective Against COVID-19: A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open-label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.”

SEPTEMBER 5, 2020
Ivermectin Moves Towards Mainstream
Recently, the National Institutes of Health (NIH) got around to formally addressing ivermectin in their COVID-19 Treatment Guidelines. Although their only recommendation is for use in clinical trials, that’s a start. TrialSite has been working tirelessly to chronicle...

SEPTEMBER 5, 2020
Temple University is the Latest Academic Medical Center to Plan an Ivermectin Trial: Does the Drug Inhibit SARS-CoV-2 Progression?
Temple University goes back to 1884, founded by Baptist Minister Russell Cornwell. Over a century later with over 40,000 students, the university prepares the largest body of professional practitioners in the State of Pennsylvania. The Lewis Katz School of Medicine...

SEPTEMBER 5, 2020
Real World Ivermectin Struggles: State Regulators Pressure Municipality to Stop Distributing the Drug as COVID-19
The Mayor of Itajaí, a major port city in the state of Santa Catarina in southern Brazil—a physician and left-leaning politician—has been distributing ivermectin kits totaling 1.5 million tablets, which have been used by about 126,000 of the estimated 200,000 people...

​SEPTEMBER 3, 2020
​Argentina’s IVERCAR Ivermectin & Carrageenan Study Shows Positive Results Targeting COVID-19
Based in the southern end of Greater Buenos Aires, Argentina, Eurnekian Public Hospital recently sponsored a clinical trial targeting COVID-19 called the IVERCAR study. The sponsor was joined by other local hospitals acting as trial site organizations. With study...

AUGUST 28, 2020
​Zagazig University Randomized Controlled Ivermectin Study Results Confirms PI Hypothesis: Drug Effective Against COVID-19
A principal investor from Zagazig University, Dr. Waheed Shouman, recently completed a randomized, open label, interventional trial titled “Use of Ivermectin as Prophylactic Option in Asymptomatic Family Close Contact for Patient with COVID-19.” Targeting 340...

AUGUST 27, 2020
Philippines Undersecretary of the Department of Health Issues Warning to Doctors Not to Prescribe Ivermectin Off Label for COVID-19
Growing off-label Ivermectin use has got the attention of the Philippines government officials, including Department of Health Undersecretary Maria Rosario Vergeire, who, in a recent press briefing, warned doctors not to prescribe the anti-parasite drug for COVID-19...

AUGUST 22, 2020
Municipality of Lucknow in UP, India, Now Distributes Free Ivermectin via Kiosks to Treat COVID-19: Is There a RWE Study Backing This Effort?
With approximately 3 million inhabitants, Lucknow is the largest city in the Indian state of Uttar Pradesh. Taking advantage of that state’s embrace of the anti-parasite drug Ivermectin as a supporting treatment for COVID-19, Lucknow’s municipal administration and...

AUGUST 18, 2020
Global Ivermectin Expert Opens up Q&A on the Antiparasitic Drug & COVID-19
World-renowned Ivermectin researcher Carlos Chaccour, PhD, recently published on the IS Global website “Questions and Answers about Ivermectin and COVID-19.” The Assistant Research Professor, BOHEMIA Chief Scientific Officer for Barcelona Institute of Global...

AUGUST 17, 2020
Topelia Therapeutics Leading Studies to Commercialize Ivermectin Targeting COVID-19 Infection
TrialSite recently reported that a California gastroenterology investigator, Dr. Sabine Hazan, was spearheading an Ivermectin-based combination study in Southern California. Now disclosed, the study collaborator includes Topelia Therapeutics, a new company formed by...

AUGUST 17, 2020
​Clinical Trials & Research News Weekly Roundup | Australian Researcher: Triple Therapy (Ivermectin, Zinc, Doxycycline) for COVID-19
Well-Respected Australian Researcher: Consider Triple Therapy (#Ivermectin, Zinc, #Doxycycline) for COVID-19: Thomas Borody touts FDA and Australian food and drug authority TGA approved Ivermectin, which he reports to use regularly in his...

AUGUST 15, 2020
Bangladesh Study Suggests that Ivermectin Combo can Treat COVID-19
The July issue of the Journal of Bangladesh College of Physicians and Surgeons includes “A Case Series of 100 COVID-19 Positive Patients Treated with a Combination of Ivermectin and Doxycycline.” Given the studies showing Ivermectin can limit SARS-CoV-2 in...

AUGUST 14, 2020
Ivermectin Breaking into American News as Doctors Come Forward & Share Treatments for COVID-19
Dr. Lauren Mickey, an ears, eyes and throat specialist at Glenwood Medical Mall in West Monroe, Louisiana, was recently interviewed by local television station Fox 14, reporting that the cheap and widely available medication Ivermectin is being used at this provider’s...

AUGUST 14, 2020
TrialSite News Original | Documentary in Peru about Ivermectin and COVID-19
TrialSite News productions introduces a new documentary special about Peru, COVID-19, and the acceptance of Ivermectin as a formally approved treatment for the novel coronavirus. Filmed right in Peru by a Peruvian film crew contracted by TrialSite, the documentary was...

AUGUST 14, 2020
​TrialSite News Releases Groundbreaking Documentary About Peru’s Use of Ivermectin for COVID-19
TrialSite News Releases Groundbreaking Documentary Series “From The Front Lines” Spotlighting the Stories of Doctors, Clinicians, and Patients From Around the World Combating COVID-19, with the First Installation Focused on Peru’s Use of Ivermectin as an economical...

AUGUST 13, 2020
More News on Dr. Borody’s Ivermectin proposal
News Corp media is the latest major media to report on the proposal of Professor Thomas Borody. This gastroenterologist received credit for developing the world’s first peptic ulcers, saving lives in the process. What’s his proposal? Make Ivermectin available for at...

AUGUST 9, 2020
​Tata Main Hospital Picks Up Ivermectin/Doxycycline Combo Regimen to Address COVID-19
Tata Main Hospital (TMH), established in 1908, has added the combination of Ivermectin and Doxycycline to its COVID-19 treatment protocol in addition to already adding Convalescent Plasma Therapy for the treatment of SARS-CoV-2 infected patients. The hospital has...

AUGUST 8, 2020
Northern Indian State of Uttar Pradesh Drops Hydroxychloroquine & Replaces with Ivermectin for COVID-19 Patients
Leadership from the great northern Indian state of Uttar Pradesh, home to the Taj Mahal, has decided to approve the use of ivermectin as a treatment and prevention of COVID-19. The drug will be used instead of hydroxychloroquine. Moving forward, ivermectin will...

AUGUST 4, 2020
Well-Respected Australian Researcher: Consider Triple Therapy (Ivermectin, Zinc, Doxycycline) for COVID-19
Thomas Borody, MB, BS, BSc (Med), MD, PhD, DSc, FRACP, FACP, FACG, AGAF, touts FDA and TGA-approved Ivermectin, which he reports to use regularly in his hospital as it evidences positive results for COVID-19 and should be used immediately to fight the pandemic. The...

JULY 27, 2020
Clinical Trials and Research News Weekly Roundup | Dr. Tarek Alam’s Ivermectin Working
Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% With Between 400-500 Patients & More Research to Come: Dr. Tarek Alam, a highly respected physician and professor of Medicine at Bangladesh Medical College (BMC),...

​JULY 22, 2020
Top California Gastroenterology Investigator Leads Phase 2 Ivermectin Clinical Trial Targeting COVID-19 Cases
A dynamic research organization in Ventura, California, called Progenabiome, LLC will initiate a Phase 2 clinical trial investigating the efficacy of ivermectin in combination with Doxycycline, much like the successful combination tested by Dr. Tarek Alam from...

JULY 20, 2020
Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% With Between 400-500 Patients & More Research to Come
Dr. Tarek Alam, a highly respected physician and professor of Medicine at Bangladesh Medical College (BMC), used two economical and easily available drugs to treat patients suffering from COVID-19 with considerable success in not only reducing the patients’ viral...

JULY 15, 2020
Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County
Please note a correction on the date mentioned in the podcast: May is the correct date instead of March. Today we have the pleasure of introducing Dr. Jean-Jacques Rajter, a Broward Health Medical Center physician, and his wife, Dr. Juliana Cepelowicz Rajter, in Florida. We...

JULY 13, 2020
​Clinical Trials and Research News Weekly Roundup: Favipiravir Cut while Ivermectin Added
Delhi’s #COVID-19 Provider Lok Nayak Hospital Cuts #Favipiravir & Adds Ivermectin & Remdesivir for COVID-19 Patients: Lok Nayak Hospital is the national capital’s first COVID-19-only facility. Although Favipiravir was recently...

JULY 12, 2020
Peru’s Universities Now Produce Ivermectin in Collaboration with Regional Health Authorities in a Fight for Survival
Pedro Ruiz Gallo National University, based in Chiclayo in the north of Peru, has committed to the production of free ivermectin to be distributed throughout this northern coastal region of Peru. Employing specialists and students out of the university’s Faculty of...

JULY 9, 2020
The Italian ‘COVER Trial’ has Regional Hospital & Pharma Research Institute Investigate Ivermectin for Early Stage COVID-19
IRCCS Sacro Cuore Don Calabria Hospital is an accredited Italian provider in the Veneto region that accommodates about 30,000 patients per year, includes 968 beds, and employs approximately 1,712. The regional provider has come together with Mario Negri Institute for...

JULY 8, 2020
​Qassim University of Saudi Arabia to Launch ‘Worldwide Trends on COVID-19’ Study to include Use of Ivermectin & Hydroxychloroquine
Saudi Arabia’s Qassim University observed with great importance the outburst of clinical research, both interventional and observational, with the onset of the pandemic. The university has taken a keen interest in better understanding how these studies can help in...

JULY 8, 2020
University of Baghdad Pilot Clinical Trial: Ivermectin plus Hydroxychloroquine & Azithromycin Superior to No Ivermectin
The TrialSite Network eagerly awaited a pilot clinical trial investigating the safety and efficacy of Ivermectin sponsored by the University of Baghdad in Iraq. Led by Professor Faiq Gorial, this study targets 100 patients in a Phase 1 clinical trial investigating the...

JULY 7, 2020
13 Promising COVID Treatments Emerging From Israel Includes Ivermectin
Scientists across the globe are working on vaccines to prevent COVID-19 infection. But in the meanwhile, and even after initial vaccines are approved, there is an urgent need for effective treatments for the respiratory disease caused by the SARS-CoV-2 coronavirus....

JULY 6, 2020
Clinical Trials and Research News Weekly Roundup | S2 E27 | Ivermectin VS Hydroxychloroquine
Ivermectin Study Reveals Fantastic Results: 100% of 60 Patients Better in an Average of Just Under 6 Days: Recently, TrialSite News reported on a study sponsored in Bangladesh by Upazila Health & Family Planning Officer’s (UHFPO)...

JULY 4, 2020
Delhi’s COVID-19 Provider Lok Nayak Hospital Cuts Favipiravir & Adds Ivermectin & Remdesivir for COVID-19 Patients
Lok Nayak Hospital is the national capital’s first COVID-19-only facility. Although Favipiravir was recently embraced in India by Glenmark Pharmaceuticals in the form of Fabiflu, this Delhi hospital has discontinued the use of the drug for COVID-19 patients. The...

JULY 3, 2020
Prominent Brazilian University Embarks on Phase 2 Ivermectin Clinical Trial
The Federal University of Sao Carlos, (UFSCar) a public research university located in Sao Carlos, in the state of Sao Paulo Brazil was established in 1968 and supports the education of over 15,000 undergraduates and about 4,700 graduate students. Ranked among the top...

JUNE 30, 2020
​President of Dominican Republic’s Largest Private Health Group Discusses the Success of Ivermectin as a Treatment for Early Stage COVID-19
The Rescue Group (Grupo Rescue) is a leading national private health network in the Caribbean nation of Dominican Republic. The Rescue Group operates three hospitals, including Punta Cana Medical Center, Bournigal Medical Center (Puerto Plata) and Canela Clinic (La...

JUNE 29, 2020
​Clinical Trials and Research News Weekly Roundup

WHO & Pan American Health Organization Position on Ivermectin Use & COVID-19: Produce Evidence via RCT. In recent episodes, we’ve covered a plethora of stories about Ivermectin from around the globe. Recently, the Pan American...

JUNE 28, 2020
​Ivermectin Study Reveals Fantastic Results: 100% of 60 Patients Better in an Average of Just Under 6 Days
Recently, TrialSite News reported on a study sponsored in Bangladesh by Upazila Health & Family Planning Officer’s (UHFPO) Office, Chakoria, Cox’ Bazar, and Abu Taiub Mohammad Mohiuddin Chowdhury, First Affiliated Hospital, Xi’an Jiaotong University. The...

JUNE 25, 2020
​WHO & Pan American Health Organization Position on Ivermectin Use & COVID-19: Produce Evidence via RCT
Recently, the Pan American Health Organization (PAHO) and the WHO (World Health Organization) came together to respond to the growing use of Ivermectin around the world (especially in South America) to treat COVID-19. Although the “Monash” study demonstrated...

JUNE 24, 2020
National University Singapore Launches Large COVID-19 Prophylaxis Study Targeting Ivermectin & HCQ
The National University of Singapore serves the island nation as a tertiary hospital, clinical training center, and research center for medical and dental faculties. With 1,160 beds serving more than 670,000 outpatients and 49,000 inpatients, NUS is ranked first in...

​JUNE 21, 2020
​Thailand’s Largest Hospital to Initiate Ivermectin Clinical Trial in COVID-19 Patients
The oldest and largest hospital in Thailand, Bangkok-based Siriraj Hospital with Mahidol University, is making a move to test Ivermectin in COVID-19 patients. Founded in 1888 by King Chulalongkorn after a cholera outbreak, the hospital today has 2,221 beds. The hospital...

JUNE 18, 2020
​100-Year-Old Discharged from Mumbai’s Rajawadi Hospital after Successful Ivermectin Treatment
A 100-year-old Indian man survived COVID-19 thanks first and foremost to his own strong will, dedicated health care team, and also the use of Ivermectin. Ramlal Mali was recently discharged from Rajawadi Hospital recently after nearly a month in the hospital. He was...

JUNE 17, 2020
​In Pursuit of Real-World Ivermectin Stories: Tales from Pathanamthitta
A request came from someone in the TrialSite Network out of India to look into a Times of India story reporting that a Pathanamthitta, Kerala-based health team has successfully treated six severe to critical COVID-19 patients with Ivermectin. The patients, including...

JUNE 17, 2020
​Dr. Roger Seheult of MedCram Talks with us About Ivermectin, Medical YouTube Channels, and More
In this podcast, we were lucky enough to have Dr.Roger Seheult from MedCram join us here to go over a variety of topics, with a focus on Ivermectin. Make sure you go over and check his YouTube out, he's been following COVID-19 closely, and studies in relation to it. Or...

JUNE 16, 2020
MedinCell Announces Great Success with Capital Raise of 15.6M€ & Use of Proceeds Includes Ivermectin Prophylactic for COVID-19
France-based Medincell recently experienced strong investor demand, leading to a capital raise of 15.6m€ ($17.6m). The funding will be deployed for research and development (R&D) activities, including the expansion and advancement of its long-acting injectable...

JUNE 15, 2020
Top Israeli Scientist & Physician Embraces Ivermectin for Clinical Trial & Raises Possibility the Drug Could Beat COVID-19
Professor Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center, Tel Hashomer, launched a clinical trial involving ivermectin, the broad-spectrum antiparasitic therapy that absolutely destroyed the novel coronavirus...

JUNE 13, 2020
Sheba Medical Center Initiates Ivermectin Study in Pursuit to Investigate Economic & Available COVID-19 Therapy
The top hospital in Israel, and the 9th worldwide, launched an Ivermectin clinical trial targeting COVID-19 patients. The elite Israeli center led by Professor Eli Schwartz seeks to show the world the potential of this economic and available FDA-approved drug. A...

JUNE 12, 2020
​How a Grassroots Health Movement Led to the Acceptance of Ivermectin as a COVID-19 Therapy in Peru
Perhaps Peru is the epicenter of the movement for off-label use of Ivermectin to treat COVID-19 patients. The doctors there swear by it. In fact, some of them curse the government for not embracing the anti-parasite drug sooner, as they believe more lives could have...

JUNE 11, 2020
Cali, Colombia Clinical Research Site Gears Up for Ivermectin Study Targeting Mild COVID-19 Patients
Yet another major ivermectin clinical trial is just a couple of weeks from initiation in Cali, Colombia, led by Dr. Eduardo Lopez, sponsored by the Centro de Estudios en Infectogia Pediatrica—The Center for Clinical Research and Comprehensive Care of Infectious Diseases....

JUNE 10, 2020
Broward Health Observational Study: Ivermectin is Associated with Lower Mortality for COVID-19 Hospitalized Patients
A team of doctors, pharmacists, and health professionals received approval from Broward Health’s Board for a retrospective, cohort study of consecutive patients hospitalized with COVID-19. They recently published the results revealing that ivermectin is associated...

JUNE 9, 2020
​Broward Health Observational Study: Ivermectin is Associated with Lower Mortality for COVID-19 Hospitalized Patients
A team of doctors, pharmacists, and health professionals received approval from Broward Health’s Board for a retrospective, cohort study of consecutive patients hospitalized with COVID-19. They recently published the results revealing that ivermectin is associated...

JUNE 7, 2020
The Watchlist Series: Covid-19, And The Ivermectin Situation

Welcome To The Watchlist Series. TrialSite News’ interview with Tarek Alam, head of the medicine department at Bangladesh Medical College, has led to considerable interest in regional hospital protocol-approved, off-label use of Ivermectin and...

JUNE 4, 2020
Monash University Continues Its Investigation into Ivermectin & Other Novel Therapies as Potential Treatments for COVID-19
Led by Dr. Kylie Wagstaff and team, Monash University, in collaboration with the Doherty Institute, triggered global interest in ivermectin, an FDA-approved marketed anti-parasitic drug, as a potential antiviral for the COVID-19 causative virus, SARS-CoV-2. The team’s...

JUNE 3, 2020
​Bangladesh’s International Centre for Diarrheal Disease Research Launches Phase II Ivermectin Clinical Trial
That Bangladesh could become a future hub of clinical research is palpable based on a number of unfolding trends. TrialSite News discussed the nation of nearly 165 million—the 8th most populated in the world—with a dynamic and rapidly growing economy, innovative and..

JUNE 3, 2020
​A Discussion with Carlos Chaccour: Ivermectin and COVID-19, Scientific Rigor in Times of Urgency
In this episode, Carlos Chaccour will talk about potential Ivermectin use for COVID-19, the safety of Ivermectin, potential Ivermectin use for malaria, Ivermectin use for other communicable diseases, and other potential uses of Ivermectin. You can view more about Carlos...

JUNE 1, 2020
ICMR—India’s National Research Agency—Investigating Ivermectin & Doxycycline as Potential Treatment for COVID-19
India’s national research organization, known as the Indian Council of Medical Research (ICMR), is now reviewing the benefits of ivermectin and doxycycline as a potential therapy for COVID-19. The combination was tested by Dr. Tarek Alam at the Bangladesh Medical...

MAY 29, 2020
Combined Military Hospital Pakistan Launches Ivermectin Clinical Trial Investigating Efficacy in COVID-19 Patients
Military hospitals known as the Combined Military Hospital are Pakistan Armed Forces hospitals situated in various cantonments of Pakistan. A legacy of the British Empire, these hospitals were originally established for British troops. After becoming the Indian Army...

MAY 29, 2020
​Mexican Hospital Starts Clinical Trial Testing Ivermectin in Serious, Non-Critical Hospitalized COVID-19 Patients
Situated in Jesus Maria, a city in the central Mexican state of Aguascalientes, a health provider called Centenario Hospital Miguel Hidalgo launched a Phase III clinical trial investigating the safety and efficacy of a treatment including hydroxychloroquine and...

MAY 27, 2020
​Great Plains Health Systems Investigate Treatment Options for COVID-19 Patients: Ivermectin Study Planned
Sanford Health and Essentia Health exemplify rock-solid American Midwestern-Great Plains health systems on the front lines of the COVID-19 pandemic. Both health systems have embraced investigational therapies to treat a previously unknown, novel coronavirus as...

MAY 26, 2020
Ivermectin Usage Accelerates While the Need for Data is Real: How About an Ivermectin Registry?
TrialSite News’ interview with Tarek Alam, head of the medicine department at Bangladesh Medical College, has led to considerable interest in regional hospital protocol-approved, off-label use of ivermectin and the antibiotic Doxycycline in patients diagnosed with mild...

MAY 25, 2020
​Prominent NYC Trust Awards $1.4m to Monash & Doherty Institute to Advance Ivermectin Research Targeting COVID-19
The growing interest in ivermectin as a possible treatment for patients infected with SARS-CoV-2, the virus behind the COVID-19 pandemic, was triggered by a laboratory experiment in a cell culture undertaken by Australian-based scientists at Monash University and the...

MAY 23, 2020
​Mexican Federal Government Commences Ivermectin Clinical Trials Targeting COVID-19
Mexico’s Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado represents the federal government’s Civil Service Social Security and Services Institute, a federal organization in that nation of 126 million that administers part of the country’s...

MAY 20, 2020
​Mansoura University Starts Pilot Clinical Trial Including Ivermectin Targeting COVID-19
Mansoura University, founded as a branch of Cairo University back in 1972, established a faculty of medicine in the middle of the Nile Delta region. According to the Times Higher Education (THE) 2020 edition, the university is ranked No. 1 in Egypt and within the top...

MAY 20, 2020
​Bolivian Region Authorizes Ivermectin as Treatment Against COVID-19
TrialSite News continues to monitor the ivermectin story with interest. Now, a city in Bolivia called Trinidad initiated a campaign to combat COVID-19 by handing out free doses of the anti-parasite drug in an effort to take on the pathogen in the eastern region of the...

MAY 17, 2020
​KKR-backed Major Indian Health Care Provider Conducting Ivermectin Study Investigating the Benefits in Combating COVID-19
Max Healthcare, a modern hospital chain in India, was founded to offer integrated, high-end, “unparalleled” health care services. With 14 hospitals, the group recently merged with KKR-backed Radiant Life Care and has entered the research war against...

MAY 16, 2020
​Taiwan’s Chang Gung University Teams with Australian Researchers to Study Potential of Ivermectin Targeting COVID-19
Australia’s Monash University, along with the University of Melbourne and Taiwan’s Chang Gung University, signed a collaboration and nondisclosure agreement centering on the development of new drugs for potential use against viruses, including SARS-CoV-2—the virus...

MAY 15, 2020
​Spanish Research Center Launches Ivermectin Clinical Trial Targeting Mild COVID-19 Patients
Clinical Universidad de Navarra and the Barcelona Institute for Global Health (ISGlobal), a center supported by "la Caixa” Foundation, have launched a clinical trial to investigate the efficacy of ivermectin against COVID-19. The study team will combine ivermectin...

MAY 13, 2020
​Observational Study ‘Usefulness of Ivermectin in COVID-19 Illness’ Raises Some Questions
Recently, a TrialSite News reader shared an interesting but not peer-reviewed or formally published study that we republish for others to review and scrutinize. The authors, Amit N. Patel, MD; Sapan S. Desai, MD, PhD, MBA; David W. Grainger, PhD; and Mandeep R....

MAY 13, 2020
Argentinian Pharma Elea Laboratories Launches POC Clinical Trial Investigating Ivermectin in Hospitalized COVID-19 Patients
Argentina’s Laboratorio Elea Phoenix S.A. (Elea Laboratories) has initiated a proof-of-concept clinical trial with 45 patients to investigate the efficacy of ivermectin as a treatment for patients infected with SARS-CoV-2. The South American pharmaceutical company...

MAY 13, 2020
Johns Hopkins to Conduct an Ivermectin Study with Hospitalized Patients Infected with COVID-19
The investigational interest in common and economical anti-parasitic drug ivermectin (Stromectol) continues to grow now as the prestigious Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins plans to launch a clinical trial in June. In hospitalized patients...

MAY 13, 2020
​Kitasato University in Discussions with Merck to Conduct Ivermectin Clinical Trial Targeting COVID-19
The word on Ivermectin as a potential approach to therapeutically countering COVID-19 is now getting out there—this time with Nikkei Asian Review. TrialSite News has followed the progression of the off-label approach of this anti-parasite drug carefully. Most...

MAY 13, 2020
​University of Kentucky Embraces Ivermectin & Other Experimental Medications in ‘Pick-the-Winner’ COVID-19 Trial
Clinical leaders from the University of Kentucky Markey Cancer Center College of Medicine and College of Pharmacy are now embarking on a novel path to investigate COVID-19 therapies. In a first in the United States, a major academic medical center has taken on...

MAY 3, 2020
University of Naples Federico II Physicians Hypothesize: Why Not Try Hydroxychloroquine & Ivermectin in Combo Against COVID-19?
Two researchers/physicians from the University of Naples Federico II—one of the oldest universities in the world—introduce the use of two drugs classically used by dermatologists for the investigational use in fighting SARS-CoV-2, the virus behind the COVID-19...

MAY 2, 2020
University of Baghdad Launches Ivermectin Clinical Trial for COVID-19 Patients
The valley where the Tigris and Euphrates Rivers flow down through what is now modern-day Iraq is literally a cradle of Civilization. After all, the world’s first writing occurs here in the form of cuneiform—the language of ancient Mesopotamia. Iraq’s University of...

APRIL 30, 2020
MedinCell Continues its Investigational Pursuit of Ivermectin Targeting COVID-19 Patients
TrialSite News followed the experimental use of Ivermectin starting with the Monash University cell culture study, revealing that the anti-parasitic zaps SARS-CoV-2 in vitro—reducing it by about 5,000 times in 48 hours. We later identified that a French biotechnology...

APRIL 26, 2020
​Tanta University PI Sponsors Ivermectin Studies Targeting COVID-19 in up to 160 Patients While Safety is a Concern for Regulators
On April 5, TrialSite News reviewed a study out of Monash University revealing that high doses of Ivermectin could “zap SARS-CoV-2 representing a 5000X reduction in the virus RNA." Hundreds of people sent us direct queries asking us to look into this further. Ten days...

APRIL 23, 2020
​Broward County Doctor Using Ivermectin Off-Label Combo on COVID-19 Patients—It is Working & Secures County Health Protocol Approval
Dr. Jean-Jacques Rajter, a Broward Health Medical Center physician, and his pulmonologist wife are “pioneering” the use of the anti-parasitic drug ivermectin on COVID-19 patients. In fact, thanks to a recent health board decision, they may actually be healing COVID-19...

APRIL 15, 2020
​Gates Foundation Funded French Research Group Commences Ivermectin Clinical Trial Targeting COVID-19
Australian researchers recently created a lot of interest in Ivermectin as they found it could zap COVID-19 in vitro. At least some French doctors have come out in support of more testing of the anti-parasitic drug, which they believe could be more effective against...

APRIL 12, 2020
FDA Cautions People Not to Take Ivermectin for COVID-19
Recently, TrialSite News reported on an Australian research team (Monash University & Peter Doherty Institute) uncovering the potential that ivermectin could potentially be used as a treatment against COVID-19. Recently, the U.S. Food and Drug Administration (FDA)...

APRIL 5, 2020
Australian Research Team Identifies Ivermectin Zaps COVID-19 in Cell Cultures
Researchers from Monash University’s Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity at Royal Melbourne Hospital recently published the results of a study revealing that Ivermectin, an approved anti-parasitic drug...

Being from South Africa, I can’t monetize my substack.
If you’d like to buy me a SA cup of coffee, go - here,
For PayPal contributions, please go - here.
Thank you.

https://linktr.ee/hewettinsite
https://andrew-hewett.pixels.com/